We’ve recently updated our valuation analysis.

CrossFirst Bankshares Valuation

Is CFB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CFB?

Other financial metrics that can be useful for relative valuation.

CFB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio2.2x

Price to Earnings Ratio vs Peers

How does CFB's PE Ratio compare to its peers?

The above table shows the PE ratio for CFB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average10.7x
HBIA Hills Bancorporation
15.7xn/aUS$657.7m
CAC Camden National
10x3.1%US$621.1m
HBT HBT Financial
10.5x10.9%US$595.5m
MSBI Midland States Bancorp
6.6x-3.4%US$586.3m
CFB CrossFirst Bankshares
9.2x4.3%US$651.0m

Price-To-Earnings vs Peers: CFB is good value based on its Price-To-Earnings Ratio (9.2x) compared to the peer average (10.7x).


Price to Earnings Ratio vs Industry

How does CFB's PE Ratio compare vs other companies in the US Banks Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a8.1%
n/an/an/a

Price-To-Earnings vs Industry: CFB is good value based on its Price-To-Earnings Ratio (9.2x) compared to the US Banks industry average (9.9x)


Price to Earnings Ratio vs Fair Ratio

What is CFB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CFB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.2x
Fair PE Ratio10.4x

Price-To-Earnings vs Fair Ratio: CFB is good value based on its Price-To-Earnings Ratio (9.2x) compared to the estimated Fair Price-To-Earnings Ratio (10.4x).


Share Price vs Fair Value

What is the Fair Price of CFB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CFB ($13.39) is trading below our estimate of fair value ($29.06)

Significantly Below Fair Value: CFB is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CFB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$13.39
US$15.60
+16.5%
9.6%US$18.00US$14.00n/a5
Nov ’23US$13.71
US$15.60
+13.8%
9.6%US$18.00US$14.00n/a5
Oct ’23US$13.05
US$15.90
+21.8%
12.3%US$18.50US$14.00n/a5
Sep ’23US$13.32
US$15.90
+19.4%
12.3%US$18.50US$14.00n/a5
Aug ’23US$13.86
US$15.90
+14.7%
12.3%US$18.50US$14.00n/a5
Jul ’23US$13.46
US$16.60
+23.3%
11.2%US$19.00US$14.00n/a5
Jun ’23US$13.23
US$17.40
+31.5%
7.8%US$19.00US$16.00n/a5
May ’23US$12.81
US$17.40
+35.8%
7.8%US$19.00US$16.00n/a5
Apr ’23US$15.70
US$18.00
+14.6%
5.0%US$19.00US$17.00n/a5
Mar ’23US$15.04
US$18.00
+19.7%
5.0%US$19.00US$17.00n/a5
Feb ’23US$15.45
US$18.00
+16.5%
5.0%US$19.00US$17.00n/a5
Jan ’23US$15.61
US$16.40
+5.1%
7.3%US$18.00US$15.00n/a5
Dec ’22US$14.00
US$16.00
+14.3%
5.6%US$17.00US$15.00n/a5
Nov ’22US$14.63
US$16.00
+9.4%
5.6%US$17.00US$15.00US$13.715
Oct ’22US$13.43
US$15.40
+14.7%
8.8%US$17.00US$13.00US$13.055
Sep ’22US$13.13
US$15.80
+20.3%
4.7%US$17.00US$15.00US$13.325
Aug ’22US$13.81
US$15.80
+14.4%
4.7%US$17.00US$15.00US$13.865
Jul ’22US$14.21
US$15.40
+8.4%
3.2%US$16.00US$15.00US$13.465
Jun ’22US$14.81
US$15.40
+4.0%
3.2%US$16.00US$15.00US$13.235
May ’22US$14.74
US$15.40
+4.5%
3.2%US$16.00US$15.00US$12.815
Apr ’22US$14.18
US$14.40
+1.6%
3.4%US$15.00US$14.00US$15.705
Mar ’22US$13.64
US$13.40
-1.8%
9.0%US$15.00US$12.00US$15.045
Feb ’22US$11.65
US$13.40
+15.0%
9.0%US$15.00US$12.00US$15.455
Jan ’22US$10.75
US$12.00
+11.6%
11.8%US$14.00US$10.00US$15.615
Dec ’21US$9.33
US$11.25
+20.6%
14.6%US$14.00US$10.00US$14.004
Nov ’21US$8.35
US$11.00
+31.7%
11.1%US$13.00US$10.00US$14.634

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies